Reported Earlier, Pulse Biosciences Highlights nPulse Cardiac Catheter Ablation Study Achieving Durable AF Treatment Outcomes With Average Procedure Time Of 65 Minutes And Low SAE Rate
Pulse Biosciences, Inc. -2.01%
Pulse Biosciences, Inc. PLSE | 19.71 | -2.01% |
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months
